Comments to FDA: Homeopathic Product Regulation Share page: Docket Number: FDA-2015-N-0540 These comments supplement oral remarks made at the April 20, 2015 hearing regarding the regulatory framework for homeopathic drug products. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements House Leaders Prioritize OMUFA Renewal, CHPA Welcomes Progress Apr 1, 2025 Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025 Press Releases and Statements CHPA Applauds New Mississippi Law to Prevent Unlawful Purchases of PSE-Containing Medicines Mar 21, 2025